Axendia to Chair “Entering the North American Market” Executive Workshop at Advamed 2008


Yardley PA, and Washington DC, September 18, 2008- Axendia Inc., a trusted advisor to Life-Science Executives on Business, Technology and Regulatory strategies, and Advamed, the world’s largest association representing the medical technology industry, today announced that Daniel R. Matlis, Axendia’s President and Founder, will chair an Executive workshop on “Entering the North American Market” at the Advamed 2008 MedTech Conference.

Developed by industry, for industry, AdvaMed 2008 is the premier medical technology conference and exhibition for business leaders, policymakers, investors, news media, patient advocates, and industry stakeholders from around the world. The Conference is schedule from September 21st thought the 24th at the Marriott Wardman Park Hotel, in Washington DC.

“The executive workshop brings significant added value to both U.S. and international participants seeking to enter the North American markets,” said Ray Briscuso, Jr., producer of AdvaMed 2008.  Because the U.S. and Canada combined markets represent the most important commercial opportunity, it is essential to understand the unique and complex environments required to do business in each country. This workshop and other AdvaMed 2008 programs will dissect and explore the major issues and concerns that every MedTech company, small and large, needs to think about at every step of the product development and commercialization cycle.” added Briscuso.

“Bringing medical devices to the North American market requires a thorough understanding of Business environment, regulatory requirements and process, its participants and the timeframe for getting the job done,” commented Daniel R. Matlis, President and Founder of Axendia.  “Understanding these requirements and processes up-front, can greatly enhance a business ability to successfully market products in North America,” Matlis added.

Presented by a panel of distinguished speakers, the workshop will provide a roadmap for the path to successfully bringing medical devices to the North American market.

Topics to be covered in this Executive Session include:

• A roadmap to successfully bringing medical devices to the North American market
o Speaker:
Daniel R. Matlis, President & Founder, Axendia, Inc.

• Government Funding Opportunities
o Speakers:
Jo Anne Goodnight, NIH SBIR/STTR Program Coordinator
Don van Dyke, Ontario Ministry of Economic Development & Trade

• The “Soft Landing”: Finding Partners in the U.S. / Canada
o Speakers:
Jeanne R. O’Connor, Vice President & Chief Development Officer, Select Greater Philadelphia
Jordan Warshafsky, Partner, Ashton Tweed, Ltd.

• The Reimbursement Landscapes
o Speaker:
Stephen Chan, Executive Director, Boston Healthcare Associates

• Regulatory Landscapes
o Speakers:
Judy Meritz, Partner, Blank Rome LLP
Carole C. Carey, Director, International Relations and External Affairs Staff, Medical Devices Coordinator for Global HBD (Harmonization By Doing) Programs, U.S FDA Center for Devices and Radiological Health

The workshop will be held on Sunday, September 21, 2:00-6:00 p.m. at the Marriott Wardman Park Hotel, in Washington DC.

For detailed information about the session, visit:

About Axendia:
Axendia Inc. is a leading analysis firm focused on the Life-Sciences and Healthcare markets. The firm provides trusted advice to Life-Science Executives on Business, Regulatory and Technology issues. Axendia’s unique perspective is a result or our focus on the Life-Sciences and Healthcare markets and a unique blend of industry experience and strategic vision. This approach enables us to successfully identify, create and execute strategies which provide lasting business value for our clients.  Additional information on Axendia’s can be found at

About AdvaMed 2008:
Designed by industry for industry, AdvaMed 2008 is the premier MedTech conference for business executives, policymakers, media, financiers, and service providers from around the world. In its inaugural year, AdvaMed 2007 attracted more than 400 organizations and 1,100 industry leaders – including 300+ CEOs, Presidents and C-level executives.

With more than 1,400 senior level attendees expected, AdvaMed 2008 is this year’s can’t miss event for networking; conducting partnering meetings; educating and influencing policymakers and the media; and participating in education sessions. Whether you need to finance, partner or license technology, AdvaMed 2008 introduces you to key decision-makers. Learn more at

Editor’s Note: Media interested in attending this session or other presentations during AdvaMed 2008 are asked to preregister. Please do so by e-mailing to obtain a complimentary media registration code in advance of the conference. Questions? Call 410-991-7027. 


Scroll to Top
Share via
Copy link